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ABSTRACT 
The zoonotic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its resultant human coronavirus disease 
(COVID-19) recently appeared as a global health threat that can cause severe respiratory infection and terminal respiratory 
distress. By the first week of April, more than 1.3 million people had been globally infected and more than 70,000 had lost their 
lives to this contagious virus. 
Clinical manifestations occur shortly after exposure, or a few days later. There is controversy regarding the transmission of the 
virus through the tear and conjunctiva; however, there are reports that the ocular surface might be a potential target for COVID-
19. The ease of transmission of this virus at close proximity presents a risk to eyecare workers. Several recommendations have 
been issued by local and national organizations to address the issue of safe ophthalmic practice during the ongoing COVID-19 
pandemic. These guidelines have numerous similarities; however, subtle differences exist. The purpose of this paper was to 
discuss measures, with a specific focus on standard precautions, to prevent further dissemination of COVID-19 at Eye Clinics. We 
have proposed procedures to triage suspected cases of COVID-19, considering emergency conditions. 
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INTRODUCTION
For the first time in December 2019, a Chinese 
ophthalmologist by the name of Dr. Li Wenliang warned 
of the risk of the emergence of a new and unusual type of 
pneumonia. On February 7, 2020, he died from COVID-19. 
This 33-year-old ophthalmologist was the first doctor to 
warn that an unusual form of respiratory infection was 
spreading. A few days after the beginning of the epidemic, 
Dr. Li Wendliang was hospitalized with a fever and cough, 
and he finally died. He was touted as a national hero in 
recognition of his sincere efforts to make the virus known 
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to the world, and many were proud of this academic 
whistleblower ophthalmologist [1, 2]. 
On December 31, China reported an unusual outbreak of 
pneumonia in Wuhan, with an unknown cause, to the 
World Health Organization (WHO). A seafood market 
appeared to be the primary source of the disease, as most 
of those affected were in contact with the wet market. On 
January 7, a new coronavirus was detected by the Center 
for Disease Control (CDC) China named as Severe Acute 
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), later 
designated as COVID-19 by the WHO [3, 4]. 
The origin of this virus is unclear, although it is structurally 
similar to the Severe Acute Respiratory Syndrome (SARS-
CoV) and the Middle East respiratory syndrome 
coronaviruses (MERS-CoV) [5]. Some studies have 
mentioned the role of bats as the main source [6], while 
others have mentioned the pangolin [7, 8]. 
Epidemiology 
By the first week of April, 2020, more than 1.3 million people 
globally had been infected and more than 75,000 had lost 
their lives to this contagious virus. In the United States, the 
COVID-19 fight entered a crucial period, as the number of 
cases topped 360,000, with almost 10,000 deaths [9].  
It has been estimated that the COVID-19 economic freeze 
could cost millions of job losses and lead to an 
unemployment rate of 32%, based on Federal Reserve 
Bank of St. Louis projections [10]. Many people have lost 
their jobs, the world is in a deep depression, and it is 
necessary to conduct multidisciplinary studies in various 
fields of medical and social sciences. Certainly, this has 
been an unexpected challenge for the world and shows 
that humans are still incapable of properly managing 
communicable diseases. 
The global impact of COVID-19 is reminiscent to that of the 
Spanish influenza (1918-1920), which infected 
approximately 500 million individuals worldwide and 
caused the deaths of 50 to 100 million people at that time 
[11]. COVID-19 carried a high mortality rate [9], in contrast 
to the mortality rate of less than 1% from influenza 
therefore there is an urgent need for effective treatment 
[12]. To date, the death toll from COVID-19 is higher than 
the total registered deaths from SARS-CoV and MERS-CoV 
[5]. In addition, it is necessary to take preventive measures 
to avert future biological crises. These might include 
monitoring wet markets and thoroughly investigating 
virology laboratories.  
Pathophysiology and Clinical Signs 
COVID-19 is an enveloped virus with a single-stranded, 
non-segmented, positive-sense RNA genome. The 
principal transmission route is through respiratory 
droplets [13-15]. The virus enters the body through the 
receptor-angiotensin converting enzyme II (ACE2), and 
blocking this receptor has been proposed as a potential 
strategy for treatment [6, 16]. Immunological evidence 
suggests that patients with severe COVID-19 might have 
cytokine storm syndrome [12], suggesting the potential of 
immunomodulatory agents against infection [17]. To date, 
there is no definitive treatment or vaccine for COVID-19, 
and most of the measures are based on the prevention of 
virus transmission. The incubation period of this viral 
infection is 2 to 14 days [18], with a mean of 
approximately 5 days, based on the present data [19]. 
Clinical signs and symptoms of COVID-19 include fever, dry or 
productive cough, fatigue, shortness of breath, myalgia, 
dizziness, confusion, headache, sore throat, anorexia, 
hemoptysis, rhinorrhea, chest pain, diarrhea, nausea and 
vomiting, and anosmia [3, 4, 20, 21]. Remarkably, the 
mortality rate associated with COVID-19 is significantly higher 
compared to the most recent seasonal influenza [22] and may 
be exacerbated in the elderly and those with comorbidities. 
Also, the mortality rate is higher in centers with a shortage of 
intensive care facilities.  In comparison with the characteristics 
of H1N1 patients, COVID-19 cases are more likely to reveal 
non-productive cough with constitutional symptoms, such as 
fatigue, gastrointestinal symptoms, and prevalence in the 
aging subgroup. Additionally, radiological features are more 
frequently presented as ground-glass opacities in COVID-19 
cases in comparison with H1N1 [23]. On the other hand, we 
believe that since COVID-19 patients require a ventilator for 
longer durations, this will indirectly limit the available supply 
and place a pressing demand for additional ventilators that is 
unexpectedly above anything we have witnessed before. 
There are no reports comparing the rate of infection 
among healthcare workers. However, with rising numbers 
and the influx of patients to the emergency room, the 
most frontline healthcare workers, paramedics, nurses, 
and doctors in all specialties, including emergency 
physicians, anesthesiologists, pulmonologists, and 
respiratory therapists are at imminent risk. 
Figures from China revealed that more than 3,300 
healthcare workers were infected as of early March, 2020, 
whereas at the end of February, 2020, at least 22 workers 
had died. In Italy, almost 20% of responding healthcare 
personnel are currently infected, and some have died [24]. 
Reports have shown that 43 healthcare workers have died 
in Iran [25]. 
COVID-19 AND THE EYE 
A close distance between the patient and the 
ophthalmologist is a risk factor for COVID-19 transmission. 
The CDC recommends social distancing, whereby people 
should be at least 2 meters apart to avoid transmission of 
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the virus. Any contact longer than a few minutes of 
exposure is considered prolonged [26]. However, in 
ophthalmic examination, the distance between the 
patient and the ophthalmologist is as close as 20 cm in 
most circumstances, and the time required for a full 
assessment including taking history, checking visual 
acuity, measuring intraocular pressure, waiting for pupil 
dilation, etc., is more than half an hour. In ocular 
examination, contact with the patient is inevitable.   
As stated in the introduction, the first report was from an 
ophthalmologist who reported a COVID-19 patient and 
died of COVID-19 himself [1]. Studies on other 
betacoronaviruses have shown that they are likely to be 
recovered through tears [27]. Even though the risk may be 
quite small, studies have shown tears as a contaminated 
ocular secretion. In a prospective interventional study, 
researchers conducted a reverse transcription-
polymerase chain reaction (RT-PCR) on the tears and 
conjunctival secretion of 30 patients with COVID-19 
pneumonia, and found that one patient with conjunctivitis 
had positive results for RT-PCR. This suggests that the virus 
might infect the conjunctiva and cause conjunctivitis [28]. 
In another study, researchers reported conjunctival 
congestion in 9 of 1099 patients with COVID-19 [29]. In a 
study from Singapore, 64 tear samples were collected 
from 17 patients with COVID-19 between days 3 to 20 of 
the onset of the primary symptom, but viral culture and 
RT-PCR showed negative results. The researchers, 
therefore, concluded that the risk of transmission through 
tears is low. Although this was the first report to assess the 
possibility of COVID-19 transmission through tears, it had 
some limitations such as a small number of subjects and 
technical limitations [30]. Although studies have shown a 
low probability of COVID-19 transmission, it is still possible 
to transmit the virus due to the patient's long stay in the 
Eye Clinic, short distance between the ophthalmologist 
and the patient, and the possibility of transmission via 
respiratory droplets. 
In a case series including 38 patients with COVID-19, 12 
patients had ocular manifestations, such as conjunctival 
congestion, epiphora, or chemosis, and these signs 
frequently appeared in cases with more severe systemic 
manifestations. Results revealed a low prevalence of 
nucleotides in conjunctival specimens of patients with 
COVID-19, whereas only one patient presented with 
conjunctivitis as the first symptom [31], showing that the 
rate of conjunctivitis was quite low. 
Feline and murine models have shown that coronaviruses 
can affect the eye. The ocular implications of human 
corona virus infections have not been extensively studied. 
However, coronaviruses are generally known to cause 
numerous ocular infections in animals. Clinical findings 
such as conjunctivitis, retinitis, anterior uveitis, and optic 
neuritis have been acknowledged in animal models [32].  
Studies show that COVID-19 is transmitted by 
asymptomatic individuals, making it difficult to control 
[33]. However, it should be noted that inadequate 
screening methods in most geographical regions might 
lead to underdiagnosis, especially in patients with less 
serious illness.  
Furthermore, a medical officer who visited Wuhan wore 
an N95 mask but without protecting his eyes reported that 
eye redness can even appear before respiratory 
symptoms [34]. 
Clinical Guidelines and Legal Issues 
Local and international ophthalmology authorities have 
published recommendations at the International Council 
of Ophthalmology (ICO) website [35], although the 
creation and implementation of evidence-based clinical 
guidelines specific for COVID-19 at the Eye Clinic, for the 
assessment, investigation, and management of high-risk 
patients is necessary. 
There is an example of comprehensive recommendations 
by the American Academy of Ophthalmology (AAO) [36] 
and a well-designed study from Hong Kong [37]. However, 
it is the responsibility of global organizations to review 
daily evidence and provide more comprehensive and 
uniform guidelines. This paper aimed to provide an 
evidence-based approach, although this may not be 
applicable to all centers, and is not a proven medico-legal 
recommendation. Subsequent information about the 
nature of COVID-19 may change these recommendations. 
It should be noted that some countries have limited 
facilities and medical resources. Healthcare resources 
should be wisely allocated, and it is the responsibility of 
healthcare policymakers to ensure fairness in the 
allocation process. 
Another important point is the legal and ethical debate on 
nosocomial COVID-19 infection. Ethics committees must 
rapidly make revisions to existing protocols. Ethics experts 
must respond to the challenge if a patient is hospitalized 
for ophthalmic surgical interventions, but becomes 
infected with COVID-19 and eventually dies, or decide 
what to do if someone complains of irreversible 
complications because of delayed surgery due to COVID-
19 prevention. 
Today, a new chapter in the history of infectious diseases 
is being written [38], and a multidisciplinary approach 
should focus on different aspects of this challenging 
health crisis. 
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GENERAL RECOMMENDATIONS 
A. Triage Protocol 
In any case, it is imperative to compare the risk of COVID-
19 transmission with the risk to the patient if not treated, 
and this risk-benefit analysis should be based on clinical 
judgment. Preventive protective measures for patients and 
clinic staff should begin outside the clinic. If feasible, a 
standardized patient screening protocol, comprising a 
concise but comprehensive review of constitutional signs 
and symptoms of COVID-19 including fever, dry or 
productive cough, fatigue, shortness of breath, myalgia, 
dizziness, confusion, headache, sore throat, anorexia, 
hemoptysis, rhinorrhea, chest pain, diarrhea, nausea and 
vomiting, anosmia, presence of conjunctivitis [3, 4, 20, 21, 
28, 31], recent travel, and contact with sick individuals 
should be accomplished over the phone prior to the 
scheduled patient visit. Patients should also be specifically 
queried about recent positive, negative, or pending COVID-
19 test results obtained for themselves and close proximity 
contacts. The ocular chief complaint should also be 
gathered remotely by phone or electronic records and 
subjected to the chief provider’s clinical judgment to 
determine visit urgency.  
The aforementioned screening protocol will hopefully reduce 
unnecessary in-person visits and allow for the stratification of 
patients into groups based on low or high COVID-19 risk and 
low or high ophthalmologic acuity. Patients with low 
ophthalmologic acuity may be appropriate for either referral 
to a later appointment date or tele-ophthalmology services.  
The demonstrated efficacy of tele-ophthalmology in rural 
settings  shows the potential for extrapolating this technique 
to other practice settings [39]. However, evidence for the use 
of electronic ophthalmology in the elderly is scarce and may 
be further limited for patients with visual impairments [40].  
If there is access to patients' contact information, they could 
be notified that their non-emergency surgery or visit has 
been postponed. They should also be reminded of COVID-19 
symptoms and contact local health authorities or a family 
doctor if appropriate.  
Table 1 presents hypothetical measures in Eye Clinics during 
the COVID-19 pandemic. At the triage desk, the patient's 
body temperature (T) is measured. Questions regarding 
clinical signs and symptoms (S) of COVID-19 include whether 
there is fever, dry or productive cough, fatigue, shortness of 
breath, myalgia, dizziness, confusion, headache, sore-throat, 
anorexia, hemoptysis, rhinorrhea, chest pain, diarrhea, 
nausea and vomiting, and anosmia, conjunctivitis, history of 
contact with COVID-19 patients (CO), or travel history (T) to 
involved geographical areas. The patient would be 
considered COST-positive if any of these factors were 
present. These high-risk patients should be directed to the 
Red Room, which is a separate room, for the examination of 
suspicious cases. Standard precautions should be 
exaggerated in this room, including the use of personal 
protective equipment (PPE) and meticulous disinfection of 
surfaces. 
In COST-negative cases, it is important to check whether the 
patient's eye condition is an emergency. If there is no 
emergency, such as the need for refraction or routine check-
up, the patient should be asked to go home until the COVID-
19 crisis is resolved. However, if the patient's condition is an 
emergency and they are COST-negative, intervention should 
be made based on clinical judgment.  
 
Table 1. Risk assessment of cases at the triage desk of Eye Clinics during 
the COVID-19 pandemic.  
 
High-Risk Patients (COST-positive) * 
Presence of Potential COVID-19 Signs and Symptoms (S) ** 
Contact with COVID-19 patients (CO) 
High Body Temperature (T) 
Travel history to high-risk areas (T) 
* Anyone who is not in the above list should be considered low risk. For 
urgent eye problems in low-risk patients, personal protective 
equipment (PPE) need only be goggles and gloves, gown, special mask 
for the ophthalmologist, and regular face mask for the patients. Note: 
This screening recommendation is based on current evidence. There is 
no priority placed on any item. ** Clinical signs and symptoms of 
COVID-19 include fever, dry or productive cough, fatigue, shortness of 
breath, myalgia, dizziness, confusion, headache, sore-throat, anorexia, 
hemoptysis, rhinorrhea, chest pain, diarrhea, nausea and vomiting, 
anosmia, and conjunctivitis [3, 4, 20, 21, 28, 31]. 
 
B. Necessity of Personal Protection 
PPE is a significant component, but only one part of the 
system protects staff and other patients from cross-infection. 
All clinical staff, including screening personnel, should wear 
PPE in congruence with regional guidelines, availability, and 
appropriateness to the symptomatology of the patient being 
treated. At a minimum, all staff should be outfitted with a 
respiratory barrier having N95 or greater filtration capacity 
and gloves. Staff who examine patients in very close 
proximity such as with a slit lamp, or who operate on, or 
otherwise instrument the eye, should use ocular protection, 
gloves, and the examiner should only touch the patients’ 
eyes using a disposable cotton-tip applicator. Patients at 
higher risk may also be outfitted with similar PPE to reduce 
spread of the virus through droplets or contact.  
PPE is necessary to reduce the risk of exposure, and may 
include gloves, goggles, face shields, water resistance gowns, 
and respiratory protective equipment, especially in the 
setting of the Red Room. Medical staff in the ophthalmology 
clinic, ward, and operation room should have standard 
insurance coverage.  
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It is clear that the re-use of masks should be avoided, as these 
might pose a risk to healthcare workers. 
Some guidelines advocate double gloving in high-risk cases 
[41]. The health protection of healthcare workers is a top 
priority. Just as in an airplane, it is recommended that one 
apply an oxygen mask themself, before helping others. 
Therefore, healthcare workers have to be healthy to provide 
a good service to their patients. Hence, maintaining the 
health of medical staff and providing protective equipment 
for them is a priority. 
C. Work Flow  
If tele-ophthalmology or phone-based consultation is not 
appropriate for a given scenario, in-person visits should be 
carried out at extended intervals, perhaps of 1 to 1.5 
hours, to avoid patient overlap. Additional and redundant 
screening should take place at the point of care for 
patients requiring in-person consultation or treatment at 
a sanctioned healthcare facility. Practices should consider 
the implementation of screening personal and high-
visibility signage outside the entrance of their facility to 
recapitulate the screening questions mentioned above, as 
well as take direct temperature measurements to screen 
for active fever. Exterior signage should also make 
patients aware of appropriate social distancing strategies, 
such as the maintenance of 2 meter spacing between 
persons. These additional screening steps may capture 
patients who were missed by phone screening or 
developed symptoms between the time of phone 
screening and presentation. We need to make sure that 
after initial screening at the entry door to the healthcare 
facility, and before entering the waiting area, all patients 
have a face mask or be provided with one. In view of the 
enormous shortage of surgical masks, the wearing of even 
a low-grade non-surgical face mask should be enforced at 
all times. No one should be allowed to walk around the 
facility without a face mask. 
Standard procedures should be developed to categorize 
patients according to their COVID-19 risk and clinical 
requirements. All patients should maintain a proper 
distance of two meters when possible and should not be 
allowed to congregate in waiting rooms or other shared 
spaces. Reduce the number of seats in the waiting room 
Always keep a few empty exam rooms so the elderly and 
immunocompromised patients can be escorted directly 
from the reception area, bypassing the waiting area. The 
waiting area should be preferably designated for low-risk 
patients only. Reduce the number of personnel by rotating 
them and space the diagnostic devices and computer 
monitors at least 6 meters from one another. Body 
temperature of personnel and the checking for symptoms 
related to infection should be assessed every day. Once 
COVID-19 screening becomes more available and cost 
effective, with a 15-minute turnaround time, one may 
consider changing the personnel every several days to 
screen for asymptomatic infection. To the best of the 
clinic’s abilities, patients should be brought directly into 
exam or procedural rooms that are as highly spaced as 
possible, and properly sanitized between patients. High-
risk patients should be considered for placement in an 
operating room with negative pressure ventilation, 
referred to as a Red Room in this paper. We suggest 
placing one slit-lamp using a proper distance in one of the 
operating rooms in the facility.  Discriminating between an 
emergency and non-emergency condition depends 
entirely on the patient's condition and the clinician’s 
judgment. Monocular patients should be considered as 
special cases.  
Table 2 presents the levels of urgency in ocular oncology 
based on considerations for the management of cases 
during the COVID-19 pandemic [42]. To step up infection 
control measures at the Eye Clinic, in partnership with 
major societies, the AAO has collated a list of urgent and 
emergency procedures generally accomplished in 
operating rooms, which may be considered as the 
reference list [36].  
For example, patients with immature cataract, epiretinal 
membrane, or those needing refractive surgery could be 
scheduled later. However, in cases such as 
endophthalmitis, prompt action should be taken. In ocular 
pathologies, malignancies should be prioritized, and those 
with a higher degree of malignancy should be given more 
attention. In particular, attention should be paid to 
situations that lead to death or disability. Manipulating a 
patient's respiratory system, such as nasal endoscopy, 
should be avoided as much as possible. 
 
D. Medical Instruments and the Clinical Environment 
The clinical environment, including instruments such as 
occluders, prisms, trial frames, trial lenses, and goniolens 
should be disinfected properly based on the official 
recommendations. 
A disposal applanation tonometer head is preferred. 
Although 70% alcohol seems to be sufficient for 
disinfection of the tonometer, it has not been shown 
effective against adenoviruses. Direct contact between 
the tonometer and the cornea may increase the risk of 
cross-infection. There is limited data available regarding 
the transmission of HIV, hepatitis B, hepatitis C, and prion 
diseases through the use of tonometers [43]. However, as 
studies have shown that diseases can be transmitted 
through close contact, the use of a non-contact tonometer 
for measurement of the intraocular pressure is 
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recommended whenever possible. Of course, the air-puff 
tonometer that causes tears to form microparticles is 
under question. 
Specific equipment requiring close proximity use, such as 
the slit lamp, should be appropriately adapted. Although 
of questionable efficacy, it has been suggested that plastic 
breath shields be placed between the slit lamp examiner 
and subject. Although there are no standard 
recommendations, the use of a slit lamp breath shield is 
recommended to reduce the transmission of droplets.  
This outbreak is an opportunity for the development of 
new directions in e-health. Perhaps another future 
direction to consider as we enter a world with 
unpredictable seasonality of COVID-19 infection, and the 
ever-present possibility of novel pandemics, is the 
development of remotely controlled slit lamps that can be 
controlled from a location separate from the patient. This 
highlights the urgency of the evolution of robotics and 
tele-medicine in ophthalmology. 
The surfaces of cell phones, keyboards, and face masks, 
which are frequently used, are among the most 
contaminated areas.    
Washing hands with soap and water before entering the 
examination room is an important practice. Instructing 
patients on proper hand washing, using brochures, 
posters, etc., is recommended. Proper ventilation should 
be available in the office. All equipment should be 
sanitized between each patient’s use by appropriately 
trained staff. Diagnostic devices are also subject to 2-
meter distancing parameters and should be appropriately 
moved or unplugged to ensure proper adherence.  
The coronavirus family can persist for up to 6 days on some 
surfaces based on some evidence [44]. It is very important to 
clean the floor, appliances, and areas that the patient is in 
contact with (such as a slit-lamp handle and chin rest). After 
each examination, the equipment used, especially the 
patient's contact point, should be disinfected by trained staff. 
Each Eye Clinic should have an affordable, effective, and low-
cost method of cleaning surfaces and equipment based on 
local protocols. One person should regularly monitor the 
implementation of these protocols, acting as the COVID-19 
Quality Control Officer.  
Gloves should be replaced after each examination. Do not 
exchange cash in the office. The patient's file and receipt 
should not be given to him, and the process should be 
carried out electronically.  
The examination room should have proper ventilation. 
Limiting conversation in the waiting and examination 
rooms should be considered.  
E. Surgical Considerations 
It is generally advisable not to perform any intervention in 
the clinic, especially for patients with positive COST 
conditions, and instead refer them to tertiary referral 
centers (Figure 1). In the present health crisis, the 
postponement of elective surgery and routine 
examinations is recommended.  
Patients must complete a COVID-19 consent form prior 
to surgery. If the patient needs surgery, a screening test 
to rule out COVID-19 prior to surgery is recommended. 
In the operating room, surgical procedures should be 
performed remotely and expeditiously. However, 
precision should not be sacrificed. It is advisable not to 
perform general anesthesia as much as possible. In 
both the clinic and the operating room, the health of 
healthcare workers is very important and should be 
protected meticulously. Their body temperature should 
be checked regularly, and they should complete a 
symptom checklist at regular intervals. Figure 2-6 show 
the general consideration to visit patients at eye clinic in 
different scenarios. 
F. Other Considerations 
Many patients use contact lenses and cannot function 
without them. We believe rigorous contact lens hygiene 
should be emphasized, but the use of contact lenses 
should be optional, unless someone has viral conjunctivitis 
or an ocular manifestation of COVID-19. 
It is necessary to pause non-COVID-19-related research 
and to convert ophthalmology teaching to online training, 
if possible. Ophthalmology promotion exams can also be 
postponed until further notice. As residents in 
governmental departments are at the frontline against 
COVID-19, economic and psychological incentive 
mechanisms for them and their families should be 
defined. Last but not least, mental health is as important 
as fighting the virus. The anxiety epidemic is growing much 
larger than the COVID-19 epidemic itself. It should be 
noted that people are naturally anxious about this 
situation.  
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Table 2. Levels of urgency based on considerations for the management of cases. Cases should be categorized into groups by local authorities based on 
clinical judgment and available resources [42]. 
Levels of Urgency 
• Emergency cases should be performed within 24 hours OR as soon as possible to preserve sight and/or life.  
• Urgent cases should be performed within 1 week, considering the availability of resources.  
• Semi-urgent cases should be performed within 1-2 months, considering the availability of resources.  
• Non-urgent cases should be deferred for at least 2-3 months or until improved availability of local operating room resources. 
 
 
 
 
 
 
 
 
Figure 1. Decision tree in the Eye Clinic during the COVID-19 pandemic. 
COST: CO, contact with COVID-19 patient; S, presence of potential signs and symptoms; F, fever; T, travel history to high-risk areas. 
* The Red Room would be equivalent to an Operating Room (OR) with a negative pressure environment, which is ideal for reducing dissemination of the 
virus beyond the OR [45]. The minimal composition of the PPE set in the Red Room should be: 
❖ Respiratory protection (N95 mask or equivalent for healthcare workers, 3 Ply face masks for patients) 
❖ Hand protection gloves (preferably double gloving in high-risk cases) 
❖ Body protection long-sleeved water-resistant gown 
❖ Eye protection goggles or face shield 
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Figure 2. Patient waiting areas should adhere to proper social 
distancing protocols. Chairs should be spaced accordingly. 
Photo Courtesy of Majid Moshirfar, MD FACS. 
 
 
 
 
 
 
 
 
Figure 3. Suggested slit lamp examination of a low-risk patient 
in clinic. Note lid manipulation should not be accomplished by 
hand. The physician is shown wearing the suggested attire of a 
surgical gown, gloves, N95 mask, surgical bonnet, and 
protective glasses. Photo Courtesy of Majid Moshirfar, MD 
FACS. 
 
 
Figure 4. Suggested slit lamp examination set up for a high-risk 
patient. Note the operating room setting with negative 
pressure ventilation capabilities. The examiner is wearing 
extensive respiratory protection, goggles, facial covering, hair 
covering, surgical gown, and gloves. Photo Courtesy of Majid 
Moshirfar, MD FACS. 
 
 
 
 
 
Figure 5. Close up viewpoint demonstrating slit lamp 
examination of a high-risk patient. A two clear plastic barriers 
can be seen attached to the binocular eye piece and lens. Photo 
Courtesy of Majid Moshirfar, MD FACS. 
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Figure 6. Glass lenses and Tonopen arranged on a disposable 
surgical underpad. Photo Courtesy of Majid Moshirfar, MD 
FACS. 
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